»
Antibodies
»
anti-Transmembrane Channel-Like 8 (TMC8) (5th cytoplasmic loop) antibody
Transmembrane Channel-Like 8 (TMC8) (5th cytoplasmic loop) antibody
| Antigen |
|
| Synonyms |
EV2, EVER2, EVIN2, FLJ40668, FLJ43684, MGC40121, MGC102701, Ever2, FLJ00400, mFLJ00400 |
|
Epitope
|
|
| Clonality |
Polyclonal |
|
Host
|
|
|
Reactivity
|
|
|
Application
|
Alternatives Immunohistochemistry (IHC), Western Blotting (WB)
|
| Catalog no. |
ABIN351058 |
| Quantity |
100 µl |
| Price |
413.33 $ Plus shipping costs $35.00
|
| Shipping to |
|
| Availability |
Ships within 7 to 10 Business Days |
|
Alternative name
|
transmembrane channel-like protein 8 (TMC8, EVER2, EVIN2) (5th cytoplasmic loop)
|
|
Swiss-Prot
|
Q8IU68
|
|
Immunogen
|
A synthetic peptide from the 5th cytoplasmic loop of human transmembrane channel-like protein 8 (TMC8, EVER2, EVIN2) conjugated to an immunogenic carrier protein was used as the immunogen.
|
|
Format
|
Lyophilized
|
|
Description
|
SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass membrane protein. TISSUE SPECIFICITY: Expressed in placenta, prostate and testis. DISEASE: Defects in TMC8 are a cause of epidermodysplasia verruciformis. It is a rare autosomal recessive genodermatosis associated with a high risk of skin carcinoma that results from an abnormal susceptibility to infection by specific human papillomaviruses. Infection leads to persistent wart-like or macular lesions. Also known as: TMC8, Epidermodysplasia verruciformis protein 2, EVER2, EVIN2.
|
|
Specificity
|
Appears to be specific for TMC8.
|
|
Application Notes
|
IHC, WB. A dilution of 1 : 300 to 1 : 2000 is recommended. The optimal dilution should be determined by the end user.
|
|
Purity
|
whole serum
|
|
Storage
|
Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
|
|
Restrictions
|
For Research Use only
|
|
Publications
|
Ramoz, Rueda, Bouadjar et al.: "Mutations in two adjacent novel genes are associated with epidermodysplasia verruciformis." in: Nature genetics, Vol. 32, Issue 4, pp. 579-81, 2002 (PubMed).
Kurima, Yang, Sorber et al.: "Characterization of the transmembrane channel-like (TMC) gene family: functional clues from hearing loss and epidermodysplasia verruciformis." in: Genomics, Vol. 82, Issue 3, pp. 300-8, 2003 (PubMed).
Olsen, Blagoev, Gnad et al.: "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." in: Cell, Vol. 127, Issue 3, pp. 635-48, 2006 (PubMed).
|
Alternatives for antigen "Transmembrane Channel-Like 8 (TMC8)", type "Antibodies"